Despite potential benefits of joint ventures between dialysis companies and nephrologists, these arrangements raise legal and ethical concerns. And because of a lack of transparency, it is impossible to study whether these concerns are borne out in practice.
No takes yet. Share an insight, caveat, or question.
Berns et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: